| Literature DB >> 22557942 |
Yutaka Shimada, Tomoyuki Okumura, Takuya Nagata, Shigeaki Sawada, Koshi Matsui, Ryota Hori, Isaku Yoshioka, Toru Yoshida, Ryusuke Osada, Kazuhiro Tsukada.
Abstract
BACKGROUND: Adequate blood supply for the reconstructed organ is important for safe esophagogastric anastomosis during esophagectomy. Recently, indocyanine green (ICG) has been used for visualization of the blood supply when anastomosis is performed in vascular surgery. To visualize the blood supply for reconstruction, we employed ICG fluorescence during esophagectomy.Entities:
Year: 2011 PMID: 22557942 PMCID: PMC3339581 DOI: 10.1007/s10388-011-0291-7
Source DB: PubMed Journal: Esophagus ISSN: 1612-9059 Impact factor: 4.230
Characteristics of the patients
| Number | |
|---|---|
| Age | 66 (49–81) |
| Sex | |
| Male | 32 |
| Female | 8 |
| Tumor location | |
| PhMt | 2 |
| CeMt | 2 |
| Ce | 3 |
| Ut | 2 |
| Mt | 19 |
| Lt | 12 |
| TNM stagea | |
| 1 | 10 |
| 2a | 5 |
| 2b | 5 |
| 3 | 18 |
| 4 | 2 |
| Preoperative treatment | |
| Chemotherapy | 10 |
| Chemoradiotherapy | 1 |
| Radiotherapy | 2 |
| None | 27 |
Ph pharynx, Ce cervical esophagus, Ut upper thoracic esophagus, Mt middle thoracic esophagus, Lt lower thoracic esophagus, Ae abdominal esophagus
aUICC TNM 6th edition
Fig. 1Near-infrared camera system
Summary of the operative procedures
| Number | |
|---|---|
| Reconstruction method | |
| Gastric tube | 36 |
| Free jejunal graft + gastric tube | 1 |
| Free jejunal graft | 2 |
| Ileo-colonic graft | 1 |
| Reconstruction route | |
| Retrosternal | 31 |
| Posterior mediastinal | 2 |
| Subcutaneous | 5 |
| Cervical | 2 |
| Additional vascular anastomosis | |
| Yes | 5 |
| No | 35 |
| Surgical position | |
| Lateral | 24 |
| Prone | 14 |
| Supine | 2 |
Fig. 2ICG fluorescence image of a gastric tube before anastomosis. Blood flow in the arteries and veins is well visualized. a The gastric tube. b ICG fluorescence image. A closed arrow indicates an artery and an open arrow indicates a vein
Fig. 3Microvessels in the gastric wall are well visualized about 2 min after ICG injection. a Image obtained under normal light. b Blood vessels and microcirculation of the gastric tube. The forceps indicates a small blood vessel in the gastric wall and closed arrow indicates microcirculation
Fig. 4ICG fluorescence image of a free jejunal graft. a Edematous graft with repeated vascular anastomosis. b Although the graft is edematous, ICG fluorescence can visualize blood flow
Fig. 5Before and after re-anastomosis between the short gastric vein and cervical vein. a ICG fluorescence shows no blood flow in the anastomosed vessel. b ICG fluorescence shows blood flow in the vessel after repeat anastomosis
Fig. 6ICG fluorescence images of a colonic graft. a The ileo-colic vessels. b There is good blood flow from the middle colic vessels
The outcome of each patient
| Patient no. | Age/gender | Stage | Tumor location | Reconstruction method | Pull-up route | Method of thoracotomy | Preoperative treatment | Associated conditions | Vascular anastomosis | Anastomotic leakage | ICG (microcirculation in the stump) | ICG (small vessel in the stump) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 59/M | T3N0M0 stage 2a | Mt | G | R | L | – | – | − | − | Observed | Observed |
| 2 | 59/M | T3N1M0 stage 3 | Mt | G | P | L | FP × 2 | Funnel chest Rectal cancer | − | − | Observed | Observed |
| 3 | 66/M | T3N0M0 stage 2a | Lt | G | R | L | – | Obesity (BMI 30) | − | − | Observed | Observed |
| 4 | 70/M | T1N0M0 stage 1 | PhMt | G | R | L | – | Pharyngeal cancer, DM | − | − | Observed | Observed |
| 5 | 62/M | T1N1M0 stage 2b | Lt | G | R | L | – | Renal failure | + | − | Observed | Not observed |
| 6 | 70/M | T3N1M0 stage 3 | Mt | G | R | L | FP × 2 | – | − | − | Observed | Not observed |
| 7 | 76/F | T3N1M0 stage 3 | Mt | G | R | L | FP + 40 Gy | – | − | − | Observed | Not observed |
| 8 | 58/M | T3N1M0 stage 3 | Lt | G | R | L | – | – | − | − | Observed | Not observed |
| 9 | 70/M | T3N1M0 stage 3 | Lt | G | S | L | – | Colon cancer | + | + | Observed | Not observed |
| 10 | 78/M | T3N1M0 stage 3 | Mt | G | R | L | – | – | − | − | Observed | Not observed |
| 11 | 56/F | T4N1M0 stage 3 | Mt | G | R | L | – | – | − | − | Observed | Observed |
| 12 | 76/M | T1N0M0 stage 1 | Ce | J | – | – | 60 Gy (9 years before) | – | + | − | Observed | Observed |
| 13 | 56/F | T2N0M0 stage 2a | Ce | J | – | – | FP | – | + | − | Observed | Observed |
| 14 | 68/M | T1N1M0 stage 2b | Mt | G | R | L | FP | – | − | − | Observed | Observed |
| 15 | 62/M | T1N1M0 stage 2b | PhMt | G + J | R | L | FP | Pharyngeal cancer | + | − | Observed | Observed |
| 16 | 71/M | T2N0M0 stage 2a | Mt | G | S | R | – | Right aortic arch | − | + | Observed | Not observed |
| 17 | 81/M | T3N1M0 stage 3 | Lt | G | R | L | – | – | − | − | Observed | Observed |
| 18 | 67/M | T4N1M0 stage 3 | CeMt | G | R | L | – | – | + | − | Observed | Not observed |
| 19 | 54/M | T1N0M0 stage 1 | Mt | G | R | L | – | – | − | − | Observed | Observed |
| 20 | 67/M | T1N0M0 stage 1 | Mt | C | S | L | – | – | − | − | Observed | Observed |
| 21 | 76/M | T1N1M0 stage 2b | Mt | G | R | L | – | – | − | − | Observed | Observed |
| 22 | 79/M | T2N0M0 stage 2a | Mt | G | R | L | – | Lung cancer | − | − | Observed | Not observed |
| 23 | 61/F | T1N0M0 stage 1 | Mt | G | R | L | – | – | − | − | Observed | Observed |
| 24 | 60/M | T1N1M1 stage 4 | CeMt | G | R | L | 60 Gy | – | + | − | Observed | Not observed |
| 25 | 67/M | T1N0M0 stage 1 | Ce | G | P | L | – | – | + | − | Observed | Not observed |
| 26 | 64/M | T2N1M0 stage 2b | AeLt | G | R | L | – | – | − | − | Observed | Not observed |
| 27 | 58/M | T3N1M0 stage 3 | Lt | G | R | P | – | – | − | − | Observed | Observed |
| 28 | 74/M | T1N0M0 stage 1 | Mt | G | R | P | – | – | − | − | Observed | Not observed |
| 29 | 68/F | T1N0M0 stage 1 | AeLt | G | R | P | – | – | − | − | Observed | Observed |
| 30 | 65/M | T1N0M0 stage 1 | UtMtLt | G | R | P | – | – | − | − | Observed | Observed |
| 31 | 71/F | T3N1M0 stage 3 | Mt | G | R | P | FP | Bilateral breast cancer | − | − | Observed | Not observed |
| 32 | 67/M | T4N1M0 stage 3 | Mt | G | S | P | DCF | – | − | + | Observed | Not observed |
| 33 | 49/F | T3N1M0 stage 3 | Mt | G | R | P | – | – | − | − | Observed | Observed |
| 34 | 61/F | T1N1M1 stage 4 | Mt | G | R | P | FP | – | − | − | Observed | Observed |
| 35 | 70/M | T3N1M0 stage 3 | Lt | G | S | P | – | – | − | − | Observed | Not observed |
| 36 | 63/M | T3N1M0 stage 3 | LtAe | G | R | P | – | – | − | − | Observed | Observed |
| 37 | 67/M | T3N1M0 stage 3 | Mt | G | R | P | FP | – | − | − | Observed | Not observed |
| 38 | 60/M | T3N1M0 stage 3 | LtAe | G | R | P | – | – | − | − | Observed | Observed |
| 39 | 47/F | T3N1M0 stage 3 | LtAe | G | R | P | DCF | – | − | − | Observed | Observed |
| 40 | 68/M | T1N0M0 stage 1 | Ut | G | R | P | – | Gastric cancer | − | − | Observed | Not observed |
G gastric tube, J free jejunal graft, C colonic graft, R retrosternal, P posterior mediastinal, S subcutaneous, L left lateral position with VATS, R right lateral position with VATS, S supine position, P prone position, FP 5-FU plus cisplatin, DCF FP plus docetaxel